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A previously healthy five-year-old girl was referred due to diplopia of sudden onset.  
The patient presented with a moderate right ptosis, left inferior oblique overaction and 
superior oblique underaction, and a positive Bielschowsky head tilt test to the left. 
This suggested a left IV nerve palsy but the right ptosis remained undefined. (Fig.1A) 
Ophthalmic and neurological examination and cranial MRI were otherwise normal.  
10 days later, a right IV nerve palsy with a right ptosis and left adduction deficit was 
evident. One month after initial presentation, a left ptosis and left IV nerve palsy were 
present. Simpson test was positive after 70sec and the ptosis improved after the ice 
pack test.  Repetitive nerve stimulation of the facial nerve demonstrated an abnormal 
decr ement. Serum acetylcholine receptor (AChR) antibody level was elevated. The 
diagnosis of ocular myasthenia gravis (OMG) was confirmed. A chest MRI excluded 
a thymoma. Treatment with pyridostigmine was initiated with a good response after 
an increase to 60 mg a day. Fourth nerve palsy resolved completely after six months 
and no generalization was observed.  
 
OMG can mimic oculomotor disorders and should be considered in children with 
unusual and alternating oculomotor symptoms. Differential diagnoses are neoplasm, 
trauma, inflammatory or vascular causes. Ophthalmic signs such as ptosis or 
ophthalmoplegia present in about 90% of children with myasthenia with or without 
generalization.1 In prepubertal children ocular symptoms appear mostly at disease 
onset and spontaneous remission is common. The risk for generalization decreases 
after two years of disease duration2 but the development of generalized symptoms is 
still possible after a period of  three years3. Untreated pediatric patients with OMG 
may have a relatively low risk of developing generalized symptoms2. Thymectomy, 
when performed before the onset of generalized symptoms, showed a trend toward 
protection from the development of generalized symptoms but no prospective data 
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are available.2 AChR antibody level, although not always positive, repetitive nerve 
stimulation and, most sensitive (if the first remain negative) stimulated single fiber 
EMG is recommended to confirm the diagnosis. Pyridostigmine is the first line 
treatment of pediatric OMG. Treatment with steroids in young children is ambivalent 
due to the side effects and may not be necessary in pediatric OMG. Immuno-
suppressive agents may reduce the conversion of adult OMG to generalized 
myasthenia gravis but seems not to influence the course of the disease in children.2, 4 
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Figure:  
Presentations with alternating sides of ptosis and 4th nerve palsy.  
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